30 suppliers listed in India.
Rapidly growing hub for cost-effective peptide API manufacturing and pharmaceutical-grade synthesis. Major suppliers supporting global clinical trials and generic markets. Indian peptide manufacturing is centered in Mumbai and across Gujarat, with CDMOs and API manufacturers scaling capacity to serve both domestic and export markets. The Indian peptide market is projected to grow at a 15.8% CAGR through 2036, supported by expanding CDMO capacity from Piramal Pharma Solutions, Auro Peptides, and Neuland Laboratories (which commissioned a $30M commercial-scale peptide facility). Indian manufacturers typically offer competitive pricing for generic peptide APIs and intermediates, with documented regulatory submissions including US Drug Master Files (DMFs) and European Certificate of Suitability (CEP) filings. Quality verification and GMP compliance should be independently confirmed.
Directory listing last reviewed October 2026.
Featured listings are paid placements. Verified suppliers with a confidence score of 80 or above appear next, in an order that rotates daily; verification is a paid review of company ownership and documents. Confidence scores are set by our editorial review. Sort by highest score to rank every listing by confidence score alone.
India's peptide capacity centers on Mumbai and Gujarat, focused on cost-effective APIs and intermediates for clinical and generic programs. Compare documented DMF and CEP filings, export history, and batch-release testing — and review peptide API manufacturers side by side rather than on price alone.
Confirm the manufacturing site behind each DMF, current GMP status from the issuing authority, and who owns the product registration in your market. Start with GMP-certified suppliers and benchmark timelines against Chinese manufacturers.
Indian peptide CDMOs and manufacturers with in-house production and GMP evidence on record in this directory include Piramal Pharma Solutions, Dr. Reddy's Laboratories, Biocon, MSN Laboratories, Alembic Pharmaceuticals, Neuland Labs, Hemmo Pharmaceuticals (Piramal Pharma Solutions) and Hetero. GMP status is site-specific, so ask for the certificate or inspection record of the facility that will make your product, then send one specification to your shortlist.
5 listed Indian suppliers have an open FDA warning letter or import alert: Shilpa Pharma, Sun Pharmaceutical Industries, Zydus Lifesciences, Cipla and Reliance Life Sciences. This matters most if product will ship to the US, where an import alert lets the FDA detain a firm's goods at the border. Each profile links the FDA record.